- Home
- ENVB vs MGRX Comparison
ENVB vs MGRX Comparison
Compare ENVB & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENVB | MGRX |
|---|---|---|
| Founded | 1994 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 7.1M |
| IPO Year | 2000 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ENVB | MGRX |
|---|---|---|
| Price | $2.25 | $0.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 676.5K | ★ 744.7K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,914,675.00 | $456,021.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.56 | $0.27 |
| 52 Week High | $13.25 | $2.75 |
Technical Indicators
Market Signals| Indicator | ENVB | MGRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 64.91 |
| Support Level | $1.82 | $0.52 |
| Resistance Level | $4.29 | $0.69 |
| Average True Range (ATR) | 0.25 | 0.07 |
| MACD | -0.12 | 0.02 |
| Stochastic Oscillator | 21.35 | 94.86 |
Price Performance
Historical ComparisonAbout ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.